Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OKTA vs GSK✓SelectedUSD · GSKOKTA vs GSK performance historyLatest closeAs of-2.06%11/17
Stock and ETF performance explorer

OKTA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+642.4%
GSK return
+85.9%
Excess return
+556.5%
Maximum drawdown
-84.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-2.3%+0.3%-1.5%
7D-2.1%-3.0%+0.9%-1.4%
30D-6.8%+0.4%-7.1%-6.9%
3M+21.9%-1.2%+23.0%+21.8%
6M+110.9%+0.9%+109.9%+108.0%
YTD+101.9%+4.0%+97.9%+94.2%
1Y+115.3%+7.3%+108.0%+104.8%
3Y+148.6%+57.1%+91.5%+98.9%
5Y-34.5%+43.0%-77.4%-46.3%
All+642.4%+85.9%+556.5%+446.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling